←
Ragothaman Yennamalli14,186 posts
Ragothaman Yennamalli avatar

Ragothaman Yennamalli

@StructBioinfo

Assoc. Prof @JNU_official_50 | Bioinformatician, He/Him. co-organizer #YIM2024, Asso.Ed @csb_journal, Spl Issue Ed: @BiophysJ Ed: BMC Bioinfo, Prot Sci, Sci Rep

◷ Joined May 2013▧ 1,221 Photos and videos
Ragothaman Yennamalli avatar
Ragothaman Yennamalli@StructBioinfo·Nov 16

Lo and behold the website has been launched for the symposium!!! silver-jubilee.github.io/sci… Thanks to SC&IS student Sougata Jana for designing it! Deadline for abstract submission: 18th Nov 2026

🚨🚨🚨Be part of the SC&IS Silver Jubilee Symposium at JNU on 27–28 Nov 2026! An excellent line of speakers (invited and alumni) & posters!🚨🚨🚨 Submit abstracts by 15 Nov and register by 20 Nov. (tinyurl.com/scis25jnu) Please share with your students! #SCIS25 #JNU 1/2

Post attachment
Giuliana Calia avatar
⟳ Ragothaman Yennamalli retweeted
Giuliana Calia@gpiacalia·Nov 12

my phd cohort had an ongoing note we added to when we read a paper than mentioned a new "ome"

Post attachment

Nobody Biologists - see that stuff? Its a stuffome

William L. Jorgensen avatar
⟳ Ragothaman Yennamalli retweeted
William L. Jorgensen@JorgensenWL·Nov 6

Announcing LigParGen 3.0: OPLS-AA parameters for organic molecules, now a free app for Mac, Windows and Linux. Paste a SMILES or draw a molecule, and get files for OpenMM, GROMACS, AMBER, CHARMM, LAMMPS and more. jorgensenresearch.com/ligpar…

0:26
Ragothaman Yennamalli avatar
Ragothaman Yennamalli@StructBioinfo·Nov 2

Our takeaway is NOT that anomaly detection has no place in AML. Rather, how we define an anomaly matters. 📄 Preprint: arxiv.org/abs/2610.39447 Comments and feedback welcome! 8/9

Ragothaman Yennamalli avatar
Ragothaman Yennamalli@StructBioinfo·Nov 2

Why? Blast and non-blast cells substantially overlap in the measured feature space. RF also learned biologically meaningful signals: CD117 and CD34 emerged as the strongest contributors in classification. So the model was not exploiting an arbitrary statistical pattern. 7/9

Ragothaman Yennamalli avatar
Ragothaman Yennamalli@StructBioinfo·Nov 2

The real challenge appeared when blasts became rare. In an external follow-up sample containing only ~1% blasts: RF: F1 = 0.587 Anomaly detectors: F1 = 0.0006–0.194 Being rare, it turns out, not necessarily makes a biological population an easily detectable “anomaly.” 6/9

Ragothaman Yennamalli avatar
Ragothaman Yennamalli@StructBioinfo·Nov 2

The result surprised us. The supervised Random Forest clearly outperformed the anomaly-detection approaches. Cross-validation: F1 = 0.911 AUROC = 0.994 External diagnostic sample (~41% blasts): F1 = 0.965 AUROC = 0.994 5/9

Ragothaman Yennamalli avatar
Ragothaman Yennamalli@StructBioinfo·Nov 2

We tested: 🔹 Isolation Forest 🔹 One-Class SVM 🔹 Local Outlier Factor 🔹 Half-Space Trees 🔹 Random Forest 🔹 UMAP + HDBSCAN Models were evaluated using patient-grouped nested cross-validation and then tested on independent samples. 4/9

Ragothaman Yennamalli avatar
Ragothaman Yennamalli@StructBioinfo·Nov 2

This raises an interesting computational question: If leukemic blasts are unusual cells within a much larger population of normal cells, can we simply treat them as anomalies? We compared three different ML strategies on the same blast-identification problem. 3/9

Ragothaman Yennamalli avatar
Ragothaman Yennamalli@StructBioinfo·Nov 2

Acute myeloid leukemia (AML) diagnosis and monitoring rely heavily on flow cytometry. But identifying blast populations still involves expert manual gating, a process that can be time-consuming, subjective, and particularly challenging when blasts become rare. 2/9

Ragothaman Yennamalli avatar
Ragothaman Yennamalli@StructBioinfo·Nov 2

🚨🚨New preprint alert! 🚨🚨 Can machine learning identify leukemic blasts from flow cytometry data? And, since blasts are abnormal/rare populations, is anomaly detection actually better suited for the task than conventional supervised learning? We put this idea to the test 1/9

Comparison of anomaly detection and supervised learning for acute myeloid leukemia blast identification: A proof-of-concept study Mezya Sezen, Pavinap Priyaa, Krishnapriya Vinod, Atul Thatai, Nitin Dayal, Ragothaman M. Yennamalli, … arxiv.org/abs/2610.39447 [𝚚-𝚋𝚒𝚘.𝙾𝚃]

Post attachment